US 6863887
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
expired A61KA61K2039/505A61K38/00
Quick answer
US patent 6863887 (Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis) held by Northwest Biotherapeutics, Inc. expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Northwest Biotherapeutics, Inc.
- Grant date
- Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/00